18. July 2018
Biotech Company Marinomed Successfully Tests New Combination Drug Against Viral Respiratory Tract Infection:
Carragelose®, a broadly effective compound for treating cold viruses, can be combined with Xylometazoline, a compound that reduces inflammation in the nasal mucosa without sacrificing efficacy. This is reflected in the findings of an in vitro study which will form the basis for developing a single drug that combats viral infections as well as freeing up blocked airways. The study was carried out by Vienna-based biotech company Marinomed Biotech AG (Marinomed) and the results have now been published in an international journal.